Maintenance of Efficacy.
NCT00796601
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Fibromyalgia
Interventions
DRUG:
Esreboxetine
DRUG:
Placebo
Sponsor
Pfizer